- Home
- NUWE vs NCNA Comparison
NUWE vs NCNA Comparison
Compare NUWE & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- NCNA
- Stock Information
- Founded
- NUWE 1999
- NCNA 1997
- Country
- NUWE United States
- NCNA United Kingdom
- Employees
- NUWE N/A
- NCNA N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- NUWE Health Care
- NCNA Health Care
- Exchange
- NUWE Nasdaq
- NCNA Nasdaq
- Market Cap
- NUWE 5.1M
- NCNA 4.3M
- IPO Year
- NUWE N/A
- NCNA 2017
- Fundamental
- Price
- NUWE $1.21
- NCNA $1.14
- Analyst Decision
- NUWE Strong Buy
- NCNA Buy
- Analyst Count
- NUWE 1
- NCNA 2
- Target Price
- NUWE $17.00
- NCNA $25.00
- AVG Volume (30 Days)
- NUWE 316.1K
- NCNA 238.3K
- Earning Date
- NUWE 03-04-2025
- NCNA 11-25-2024
- Dividend Yield
- NUWE N/A
- NCNA N/A
- EPS Growth
- NUWE N/A
- NCNA N/A
- EPS
- NUWE N/A
- NCNA N/A
- Revenue
- NUWE $8,969,000.00
- NCNA N/A
- Revenue This Year
- NUWE $2.18
- NCNA N/A
- Revenue Next Year
- NUWE $25.75
- NCNA N/A
- P/E Ratio
- NUWE N/A
- NCNA N/A
- Revenue Growth
- NUWE 3.66
- NCNA N/A
- 52 Week Low
- NUWE $0.92
- NCNA $0.96
- 52 Week High
- NUWE $27.65
- NCNA $19.40
- Technical
- Relative Strength Index (RSI)
- NUWE 53.66
- NCNA 43.15
- Support Level
- NUWE $0.99
- NCNA $0.96
- Resistance Level
- NUWE $1.26
- NCNA $1.37
- Average True Range (ATR)
- NUWE 0.08
- NCNA 0.15
- MACD
- NUWE 0.02
- NCNA -0.00
- Stochastic Oscillator
- NUWE 81.48
- NCNA 26.09
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.